Distance as an Obstacle to Clinical Trial Access: Who Is Affected and Why It Matters

View Resource

Evaluates factors associated with geographic remoteness of 60 miles or more from the nearest phase 2 or 3 clinical trial for a variety of health conditions. Discusses American Indian reservations and rural areas, and provides data on demographic factors associated with remoteness including race and ethnicity, educational attainment, and poverty. Includes a county-level interactive map of clinical trial remoteness for health conditions including cancers, substance use disorder, diabetes, obesity, COPD, stroke, and more. Requires the creation of a free account to view.

Andrew Friedson, Bumyang Kim, Maggie Switek, Lawson Mansell

06/2024

Document

The Milken Institute

Access · American Indian or Alaska Native · Arthritis · COVID-19 · Cancer · Cardiovascular disease · Chronic respiratory conditions · County-by-county data · Dementia · Diabetes · Educational attainment · HIV and AIDS · Infectious diseases · Mental health conditions · Obesity and weight control · Poverty · Racial and ethnic groups · Rural-urban differences · Statistics and data · Substance use and misuse